New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2013
08:04 EDTPHG, ICADiCAD, Invivo announce global strategic agreement for MRI solutions
Invivo, a Philips Healthcare Business (PHG), and iCAD, Inc. (ICAD) announced that the companies have entered into a global research, development, and commercial agreement. Under the agreement, iCAD will develop advanced MRI image analysis software products which Invivo will incorporate into its suite of MRI product solutions for global commercial sale. The first products are anticipated to be available in Q2 2013. The initial focus of the partnership will be the release of a next generation platform for prostate and breast imaging. Additional new product releases are also anticipated beginning the second half of 2013.
News For ICAD;PHG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2015
05:46 EDTPHGPhilips wise to sell Lumileds stake, DigiTimes Research reports
Subscribe for More Information
April 7, 2015
08:08 EDTICADiCAD announces positive results from trial evaluating the Xoft System
iCAD announced first-year data from the company's ExBRT trial evaluating the Xoft System for the treatment of early stage breast cancer will be presented at the American Brachytherapy Society Annual Meeting in Orlando, FL. "Early results from the ExBRT study suggest that this short course of full dose radiation in a single treatment delivers good to excellent cosmetic results in 94% of cases and very few low-grade adverse events in select patients with early-stage breast cancer," said Dr. Nisar Syed, investigator of the multi-center ExBRT study. "I am very encouraged by the results as IORT may also improve patient quality of life by greatly reducing the number of treatments patients receive when compared to EBRT."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use